SciShow News explains the science behind the latest efforts to stop the spread of ebola: including airport screenings, treatments for patients, and developments in the search for a vaccine.

Bitten by a venomous snake? There's hope! French scientist Albert Calmette developed the first snake antivenom in the late 1890s, and did such a good job that we use his technique to this day. Antivenom works by stimulating the...

Hank briefs us on a fascinating project that aims to map the anatomical and functional pathways of the brain - a neural network called the human connectome.

An ethically questionable new genetic technique attempts to grow human organs inside of pigs.

America's last major epidemic was the HIV/AIDS crisis of 1980s and 1990s. In order to better understand our current circumstances, Danielle is looking back at the legacies of action and inaction surrounding HIV/AIDS and how the...

This week on Nature League, Brit discusses the concept of model organisms and offers some arguments for and against their use. Get your Critically Endangered Sharks poster here! Only on sale through May 30th.

President Trumpês proposed budget will cut $7 billion in NIH funding - over 20% of the total NIH budget. You might be wondering, where does that NIH money get spent? This week, we interviewed some UCSD Neuroscientists to tell you about...

President Trumpês proposed budget will cut $7 billion in NIH funding - over 20% of the total NIH budget. You might be wondering, where does NIH money go? This week, we heard from scientists across the country about their NIH funded...

The peer review process for awarding NIH grants has some problems. Less money is being awarded, and the buying power of the NIH has declined. What's going on with the peer review system?

The administration has proposed a cut of nearly $6 billion to the NIH budget in 2018. They say that no research will be directly affected because the NIH budget will trim –inefficient,” "wasteful" overhead payments. But what are those...

The antiviral drug remdesivir is showing promise as a COVID-19 treatment in early U.S. clinical trials, though other research hasn’t seen as much success.

U.S. President-elect Donald Trump surprised all with another debatable pick for the National Institutes Of Health (NIH). Trump announces that Indian-American Jay Bhattacharya, a fierce critic of Covid-19 lockdown, will work as the...

CRISPR may be a cure, but clinical trials may lack volunteers because of black patients' mistrust of biased and unethical medical practices.

More than 400,000 service members suffered traumatic brain injuries in Iraq and Afghanistan. Most returned to duty. Many will have enduring symptoms.

One study found that more than half of U.S. adults who got COVID or lost income during the pandemic struggle with medical debt.

While the CDC says risk to Americans is still low, U.S. researchers and scientists are hard at work exploring possible treatments for coronavirus.

Cornell University researchers found President Trump was linked to a third of published "misinformation conversation" they studied on coronavirus.

This week, researchers began testing 30,000 test subjects in the NIH’s and drugmaker Moderna’s Phase 3 clinical trials <br/>
on a virus vaccine.

The head of the National Institute of Allergy and Infectious Diseases said the testing system in the U.S. "is not geared to what we need right now."

AT-100 could help keep COVID-19 patients from going into respiratory distress and off of ventilators.

The country's top infectious disease doctor says this year's vaccine is only a 58% match for influenza B/Victoria, which most often affects kids.

It's been over 20 years since the federal government has funded gun violence prevention research.

One year into the Biden administration and COVID numbers are reaching record highs as the president's approval rating slips.

Lawmakers approved $25 million for the CDC and the NIH. It's the first time Congress has authorized funding for gun violence research in decades.